The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, pyschiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.
News about Bristol-Myers Squibb
He'll have to recuse himself from decisions involving more than 20 companies.
A government watchdog will probe the orphan drug program.
He thinks the pharma giant is a buyout target.
A Merck drug may soon become dominant in lung cancer.
They're about to face a lot more competition.